Join to view full profile
820 N Chelan AveWenatchee, WA 98801
Phone+1 509-663-8711
Fax+1 509-664-3417
Dr. Garrison is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
San Antonio Uniformed Services Health Education ConsortiumFellowship, Hematology and Medical Oncology, 1998 - 2001
Madigan Army Medical CenterResidency, Internal Medicine, 1995 - 1998
Boston University School of MedicineClass of 1995
Certifications & Licensure
WA State Medical License 2006 - 2027
TX State Medical License 2002 - 2008
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification SoftLab, SCC Soft Computer, 2013-2014, 2016-2017
Clinical Trials
- Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer Start of enrollment: 2008 Apr 23
- Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting Start of enrollment: 2010 Dec 02
- Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer
Publications & Presentations
PubMed
- 12 citationsSocial determinants of health and access to allogeneic hematopoietic cell transplantation for acute myeloid leukemia.Natalie Wuliji, Salene M W Jones, Ted Gooley, Aaron T Gerds, Bruno C Medeiros
Blood. 2025-06-19 - 15 citationsAn 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm patients with AML.Mohamed L Sorror, Ted A Gooley, Barry E Storer, Aaron T Gerds, Mikkael A Sekeres
Blood. 2023-01-19 - Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia.Mohamed L Sorror, Barry E Storer, Amir T Fathi, Andrew Brunner, Aaron T Gerds
Blood. 2021-08-05
Lectures
- Limitations to Receiving Allogeneic Hematopoietic Cell Transplantation for Treatment of Acute Myeloid Leukemia: A Large Multi-Center Prospective Longitudinal Observati...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Survival Differences Among Patients (pts) with Acute Myeloid Leukemia (AML) Treated with Allogeneic Hematopoietic Cell Transplantation (HCT) Versus Non-HCT Therapies: ...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:










